BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2021 12:05:59 PM | Browse: 444 | Download: 823
 |
Received |
|
2020-08-11 15:25 |
|
Peer-Review Started |
|
2020-08-11 15:25 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-12-18 00:41 |
|
Revised |
|
2020-12-18 19:34 |
|
Second Decision |
|
2021-02-04 03:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-02-12 04:16 |
|
Articles in Press |
|
2021-02-12 04:16 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-03-01 00:30 |
|
Publish the Manuscript Online |
|
2021-03-11 12:05 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lisa B E Shields, Michael W Daniels, Nataliya Mar and Arash Rezazadeh Kalebasty |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arash Rezazadeh Kalebasty, MD, Doctor, Division of Hematology/Oncology, Department of Medicine, UCI Medical Center, 101 The City Drive South, Zot 4061, Orange, CA 92868, United States. arez@uci.edu |
| Key Words |
Oncology; Testicular cancer; Thromboembolic; Cisplatin; Pulmonary embolism; Thromboprophylaxis |
| Core Tip |
While cisplatin-based chemotherapy has significantly lengthened the survival of patients with testicular germ cell tumor, it is associated with a high rate of thromboembolic events (TEE). We analyzed 68 patients who were diagnosed with testicular germ cell tumor and received platinum-based chemotherapy. A total of 19 (28%) patients experienced a TEE following orchiectomy which occurred during chemotherapy in 13 (68%) of these patients. Patients with a higher pathologic stage (stage III) were significantly more likely to experience a TEE compared to patients with a lower stage. Randomized studies to evaluate the safety and efficacy of prophylactic anticoagulants are necessary in this young patient population generally without medical co-morbidities. |
| Publish Date |
2021-03-11 12:05 |
| Citation |
Shields L, Daniels M, Mar N, Rezazadeh Kalebasty A. Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy. World J Clin Oncol 2021; 12(3): 183-194 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i3/183.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i3.183 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
